Opinion

Video

Final Thoughts

Author(s):

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA,Amir Ali, PharmD, BCOP

The panel discussion concludes with final thoughts on the future landscape of newly diagnosed multiple myeloma.

Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
Multiple myeloma cells | Image Credit: © LELISAT - stock.adobe.com
March 26th 2025

Long-Term Follow-Up Data from the CASSIOPEIA Trial Show Continued MRD, PFS Benefit in Multiple Myeloma

Alexandra Gerlach, Associate Editor
The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma
January 31st 2025

The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma

Alexandra Gerlach, Associate Editor
Blood cancer cells | Image Credit: © stock_acc - stock.adobe.com
March 17th 2025

Elotuzumab-Based Regimen Demonstrates Efficacy in Relapsed/Refractory Multiple Myeloma

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition
April 17th 2023

Pharmacy Focus: Oncology Edition - Consider Treatment Sequences Carefully in Myeloma

Microscopic view of multiple myeloma cells attacking bone marrow | Image Credit: © Diane - stock.adobe.com
March 12th 2025

Dexamethasone Shows Promise as Cost-Effective Alternative to Tocilizumab for Cytokine Release Syndrome in RRMM

Alexandra Gerlach, Associate Editor
Multiple Myeloma is a cancer of plasma cells, a type of white blood cell found in bone marrow - Image credit: kamonrat | stock.adobe.com
March 7th 2025

Pharmacists Play an Essential Role in Bispecific Therapy for Multiple Myeloma

Kennedy Ferruggia, Assistant Editor